Yeah I couldnt tell ya, I am sure it varies greatly and realistically until you get into a Phase 1 trial with humans the data is only as good as an indicator. Most of Phase 1 trials are about getting the dosage correct with the least amount of side effects and yet experiencing the best results.
News 
Market Data 
Discover 
